| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/21/2006 | WO2006097090A1 Retinol for reducing risk factors of arteriosclerosis and/or increasing insulin sensitivity |
| 09/21/2006 | WO2006097043A1 Bacopa monnieri extract and process for preparation and use thereof |
| 09/21/2006 | WO2006097030A1 Bisheterocycle tandem compounds useful as antiviral agents, the uses thereof and the compositions comprising such compounds |
| 09/21/2006 | WO2006097029A1 A self-directing and self-assembled quantum conductive junction of nano-medicine and its preparation process |
| 09/21/2006 | WO2006097014A1 A process for preparing pramipexole |
| 09/21/2006 | WO2006096996A1 Compositions and methods for increasing metabolism, thermogenesis and/or muscular definition |
| 09/21/2006 | WO2006096995A1 Sulfur oligonucleotides having antiviral activities |
| 09/21/2006 | WO2006096970A1 Synthetic anti-candida albicans oligosaccharide based vaccines |
| 09/21/2006 | WO2006096955A1 Vehicle for topical delivery of anti-inflammatory compounds |
| 09/21/2006 | WO2006096914A1 A topical analgesic composition |
| 09/21/2006 | WO2006096913A1 A topical anaesthetic composition |
| 09/21/2006 | WO2006096911A1 Novel potassium channel blockers and uses thereof |
| 09/21/2006 | WO2006081182A3 Antibacterial agents |
| 09/21/2006 | WO2006080412A3 Cyanopyrrolidine derivative-containing composition for solid pharmaceutical preparations, solid pharmaceutical preparation containing the composition, and process for producing the solid pharmaceutical preparation |
| 09/21/2006 | WO2006079556A3 Substituted 5-phenyl pyrimidines i in therapy |
| 09/21/2006 | WO2006079547A3 Spm 927 for add-on therapy of schizophrenia |
| 09/21/2006 | WO2006079077A3 Use of diltiazem or analogs thereof as modulators of ghrelin receptor |
| 09/21/2006 | WO2006078711A3 Diazabenzo[de]anthracen-3-one compounds and methods for inhibiting parp |
| 09/21/2006 | WO2006076231A8 Combination therapy for the treatment of diabetes and conditions related thereto and for the treatment of conditions ameliorated by increasing a blood glp-1 level |
| 09/21/2006 | WO2006076131A3 Chemical compounds |
| 09/21/2006 | WO2006076124A3 Stable, non-crystalline formulation comprising olanzapine |
| 09/21/2006 | WO2006072830A3 Polymorphic and amorphous forms of 2-{3-[(e)-2-(4,6-dimethyl-pyridin-2-yl)-vinyl]-1h-indazol-6-ylamino}-n-(4-hydroxy-but-2-ynyl)benzamide |
| 09/21/2006 | WO2006072348A3 Alkinyl-substituted thiophenes |
| 09/21/2006 | WO2006072239A3 Use of cobalamines for treating intestinal diseases |
| 09/21/2006 | WO2006067138A3 Injectable veterinary composition |
| 09/21/2006 | WO2006066913A3 Benzamide substituted imidazo- and pyrolo-pyridines as protein kinase inhibitors |
| 09/21/2006 | WO2006066070A3 Prodrug constructs of pyrimidinone compounds as calcilytics |
| 09/21/2006 | WO2006065590A3 Pyridine and pyrimidine antiviral compositions |
| 09/21/2006 | WO2006063813A3 3-arylalkyl-substituted and 3-heteroarylalkyl-substituted-1,2,4-triazin-5(2h)-ones |
| 09/21/2006 | WO2006063462A9 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 09/21/2006 | WO2006063294A3 Novel inhibitors of histone deacetylase for the treatment of disease |
| 09/21/2006 | WO2006063189A3 Multi-layered chewing gum tablet with quick disintegration layer |
| 09/21/2006 | WO2006061373A3 Tetrahydropyridin-4-yl indoles with a combination of affinity for dopamine-d2 receptors and serotonin reuptake sites |
| 09/21/2006 | WO2006060712A3 Potassium salt of an hiv integrase inhibitor |
| 09/21/2006 | WO2006060697A9 Methods for administering dpd inhibitors in combination with 5-fu and 5-fu prodrugs |
| 09/21/2006 | WO2006060456A3 Indole derivatives for use as ppar ppar active compounds |
| 09/21/2006 | WO2006055878A3 Exfoliating skin care product |
| 09/21/2006 | WO2006055760A9 Triazole compounds that modulate hsp90 activity |
| 09/21/2006 | WO2006055573A3 Methods of using pde v inhibitors for the treatment of congestive heart failure |
| 09/21/2006 | WO2006055525A3 Protein tyrosine phosphatase inhibitors and methods of use thereof |
| 09/21/2006 | WO2006048261A3 Oral solid dosage forms containing a low dose of estradiol |
| 09/21/2006 | WO2006048152A3 Dicarboxamide derivatives and their use as factor xa inhibitors |
| 09/21/2006 | WO2006047466A3 Ophthamological drugs |
| 09/21/2006 | WO2006047330A3 Methylphenidate analogs and methods of use thereof |
| 09/21/2006 | WO2006047162A3 Compositions and methods for treatment of disease caused by yersinia spp infection |
| 09/21/2006 | WO2006046734A3 Novel aminopyridine derivatives having selective aurora-a inhibitory effect |
| 09/21/2006 | WO2006045037A3 Truncated fragments of alpha-synuclein in lewy body disease |
| 09/21/2006 | WO2006044826A3 Thiophens and their use as anti-tumor agents |
| 09/21/2006 | WO2006044101A3 Method and composition for supplementation of nutritional deficiencies in renal patients |
| 09/21/2006 | WO2006043182A3 Screening assays for inhibitors of a staphylococcus aureus siderophore |
| 09/21/2006 | WO2006037023A3 Use of inhibitors of 24-hydroxylase in the treatment of cancer |
| 09/21/2006 | WO2006034064A3 Process for sterilization of and cyanoacrylate adhesive compositions and devices |
| 09/21/2006 | WO2006031267A3 Rna interference suppression of neurodegenerative diseases and methods of use thereof |
| 09/21/2006 | WO2006030440A3 Use of tellurium compounds as adjuvants |
| 09/21/2006 | WO2006020912A3 Treatments for congestive heart failure |
| 09/21/2006 | WO2006010605A3 Sustained release pharmaceutical particulate composition comprising venlafaxine |
| 09/21/2006 | WO2006010557A8 D-glucopyranosyl phenyl-substituted cyclene, medicaments containing these compounds, their use, and method for the production thereof |
| 09/21/2006 | WO2006002422A9 Compounds for immunopotentiation |
| 09/21/2006 | WO2006002421A3 Modulators of atp-binding cassette transporters |
| 09/21/2006 | WO2005120456A3 Formulation of eletriptan |
| 09/21/2006 | WO2005094202A3 Iron sucrose complexes and method of manufacture thereof |
| 09/21/2006 | WO2005085255A8 The extract of bulbophgllum radiatum lindl and the preparation and the use |
| 09/21/2006 | WO2005084662A8 The euphorbia lunulate bge extractant and production method and use thereof |
| 09/21/2006 | WO2005081954A3 Inhibitors of protein tyrosine phosphatase 1b |
| 09/21/2006 | WO2005077105A3 Reduction of hiv-1 replication by a mutant apolipoprotein b mrna editing enzyme-catalytic polypeptide-like 3 g (apobec3g) |
| 09/21/2006 | WO2005055932A3 Therapeutic combinations and methods including irm compounds |
| 09/21/2006 | WO2005037207A3 Arylalkyl-piperazine derivatives for the treatment of conditions ameliorated by monoamine reuptake including vasomotor symptoms (vms) |
| 09/21/2006 | WO2005007137A8 Tablets containing ambroxol |
| 09/21/2006 | WO2004093802A3 Prevention of deficits in neurogenesis with anti-inflammatory agents |
| 09/21/2006 | US20060212109 Delivery of therapeutic capable agents |
| 09/21/2006 | US20060212025 Method and apparatus for acne treatment |
| 09/21/2006 | US20060211865 Use of pyridine N-oxide analogs at doses which do not induce emesis |
| 09/21/2006 | US20060211860 Compounds for the treatment of Alzheimer's disease |
| 09/21/2006 | US20060211857 6,7-Oxygenated steroids and uses related thereto |
| 09/21/2006 | US20060211856 Glycolipids and analogues thereof as antigens for NK T cells |
| 09/21/2006 | US20060211774 Method of diagnosins a genetic susceptibility for bone damage |
| 09/21/2006 | US20060211773 1-(12-Amino-4,9-diazadodecyl)-2-methyl-3-hydroxy-4(1H)-pyridinone; increase transport across a cell membrane in order to increase the effectiveness of chelation therapy; metal (iron) overload condition, anticarcinogenic, antitumor agent; positively charged at physiological pH; reducing oxidative stress |
| 09/21/2006 | US20060211772 Processes for the preparation of atomoxetine hydrochloride |
| 09/21/2006 | US20060211771 Isoalkyl-substituted; N-[2-(1,3-dimethylbutyl)phenyl]-2-(trifluoromethyl)benzamide; fungicides and bactericides for protection of crops |
| 09/21/2006 | US20060211770 Enhanced bimatoprost ophthalmic solution |
| 09/21/2006 | US20060211769 Selectively inhibit matrix metalloproteinases(MMP);selectively bind to integrin alpha v beta 3 and blocks the interaction of integrin alpha v beta 3 with matrix metalloproteinase 2; iminodiacetamide |
| 09/21/2006 | US20060211768 Means for the modulation of processes mediated by retinoid receptors and compounds useful therefor |
| 09/21/2006 | US20060211766 Gelled immunomodulating topical compositions and a method of treating warts and other human papilloma virus skin infections |
| 09/21/2006 | US20060211765 Novel compounds |
| 09/21/2006 | US20060211764 Cell activator, process for producing cell activator and apparatus therefor |
| 09/21/2006 | US20060211763 Treatment with Statin and Omega-3 Fatty Acids and a Combination Product Thereof |
| 09/21/2006 | US20060211762 Omega-3 fatty acids and dyslipidemic agent for lipid therapy |
| 09/21/2006 | US20060211761 Hmg-coa-reductase inhibitors |
| 09/21/2006 | US20060211760 Indolamide derivatives which possess glycogen phosphorylase inhibitory activity |
| 09/21/2006 | US20060211759 Bis-heterocyclic compounds with antitumour and chemosensitising activity |
| 09/21/2006 | US20060211758 M3 muscarinic acetylcholine receptor antagonists |
| 09/21/2006 | US20060211757 Inhibitors of murine double minute-2(mdm2) such as (2'r,3's,4'r,5'r)6-chloro-4'-2,2-dimethyl-propyl-2'-(2,2-dimethyl-propyl)-2-oxo-1,2-dihydro-spiro[indole-3,3'-pyrrolidine]-5'-carboxylic acid(3-morpholin-4-yl-propyl)-amide, used for inducing apoptosis and cell cycle arrest; antiproliferative agents |
| 09/21/2006 | US20060211756 Novel heterocycle derivatives useful as selective androgen receptor modulators (SARMs) |
| 09/21/2006 | US20060211755 3-oxo-1, 3-dihydro-indazole-2-carboxylic acid amide derivatives as phospholipase inhibitors |
| 09/21/2006 | US20060211754 Compositions comprising N-propanoyl derivatives of amino acids, aminocarbohydrates and derivatives thereof |
| 09/21/2006 | US20060211753 Method and composition which reduces stimulation of muscles which dilate the eye |
| 09/21/2006 | US20060211752 Use of phenylmethimazoles, methimazole derivatives, and tautomeric cyclic thiones for the treatment of autoimmune/inflammatory diseases associated with toll-like receptor overexpression |
| 09/21/2006 | US20060211751 Zolmitriptan crystal forms |
| 09/21/2006 | US20060211750 Triazole derivatives |
| 09/21/2006 | US20060211749 Treatment with omega-3 fatty acids and PPAR agonist and/or antagonist and a combination product thereof |